Infographic: The battle for medication adherence
Drugmakers and providers alike struggle to find the best tools, words, and technologies that will improve adherence rates among patients with chronic diseases.
Data/Analytics
Study: One-third of new drugs report safety issues
Drugs approved through the accelerated approval pathway, as well as psychiatric drugs, were more likely to have a safety issue following FDA approval.
U.S. drug spend grew by 6% in 2016, the lowest rate in two years
This is likely due to fewer product launches and lower price increases.
Day 2 at Health Datapalooza
The market for health data and technology is growing, but the industry must also address concerns about privacy, standards, and diversity.
Day 1 at Health Datapalooza
HHS Secretary Tom Price calls for health IT that works for clinicians and better interoperability.
Pharma R&D partnerships are on the rise: report
This is likely due, in part, to the increasingly complex nature of new specialty drugs.
Off-label legal settlements do little to change prescribing patterns
An analysis of claims data found that an off-label settlement for one Eli Lilly drug did not significantly change how often it was prescribed off-label after the settlements.
Large teaching hospitals more prone to breaches
These facilities may be more prone to attack because there are more people at them with access to private patient data, whether to conduct medical research or educate new healthcare professionals.
Is a Crisis Brewing for Watson Health?
In the wake of MD Anderson’s costly failure with IBM’s Watson supercomputer, a Watson backlash brewing in biopharma may lead to a moment of reckoning in life sciences.
Infographic: The physician view on patient data
A WebMD survey finds that patients are more engaged when they share their own health with their doctors.
Want to read more?
Please login or register first to view this content.
